Lua Labs Report — Night Work, Rotating Shifts, and Sustained Hormonal Disruption

Date: 2026-06-17 Researcher: Lua Labs Classification: Chronobiology Line: L4 — Hormonal chronobiology Subtopic: 4.5 — Night work and hormonal disruption: epidemiological evidence in LATAM women

External Sources

Hu F, Han X, Chen X, et al. (2023). "Shift work and menstruation: A meta-analysis study." SSM - Population Health. DOI: 10.1016/j.ssmph.2023.101542. https://pubmed.ncbi.nlm.nih.gov/37954014/
Lawson CC, Whelan EA, Lividoti Hibert EN, et al. (2011). "Rotating Shift Work and Menstrual Cycle Characteristics." Epidemiology. DOI: 10.1097/EDE.0b013e3182130016. https://pubmed.ncbi.nlm.nih.gov/21364464/
Mayama M, Umazume T, Watari H, et al. (2020). "Frequency of night shift and menstrual cycle characteristics in Japanese nurses working under two or three rotating shifts." Journal of Occupational Health. DOI: 10.1002/1348-9585.12180. https://pmc.ncbi.nlm.nih.gov/articles/PMC7660642/
Wang Y, Gu F, Deng M, et al. (2016). "Rotating shift work and menstrual characteristics in a cohort of Chinese nurses." BMC Women's Health. DOI: 10.1186/s12905-016-0301-y. https://pubmed.ncbi.nlm.nih.gov/27165207/
Davis S, Mirick DK, Chen C, Stanczyk FZ. (2012). "Night shift work and hormone levels in women." Cancer Epidemiology, Biomarkers & Prevention. DOI: 10.1158/1055-9965.EPI-11-1128. https://pubmed.ncbi.nlm.nih.gov/22315366/
Bracci M, Ciarapica V, Copertaro A, et al. (2014). "Rotating-shift nurses after a day off: peripheral clock gene expression, urinary melatonin, and serum 17-beta-estradiol levels." Scandinavian Journal of Work, Environment & Health. DOI: 10.5271/sjweh.3414. https://pubmed.ncbi.nlm.nih.gov/24402410/
Fustinoni S, Campo L, Colosio C, et al. (2025). "Steroid hormones, vitamin D and melatonin in rapidly rotating shift female hospital workers." Toxicology Letters. DOI: 10.1016/j.toxlet.2024.11.013. https://pubmed.ncbi.nlm.nih.gov/39615663/
Brum MCB, Dantas Filho FFS, Schnorr CC, et al. (2022). "Effect of night-shift work on cortisol circadian rhythm and melatonin levels." Sleep Science. DOI: 10.5935/1984-0063.20220034. https://pubmed.ncbi.nlm.nih.gov/35755906/
Stock D, Knight JA, Raboud J, et al. (2019). "Rotating night shift work and menopausal age." Human Reproduction. DOI: 10.1093/humrep/dey390. https://pubmed.ncbi.nlm.nih.gov/30698677/
Khan D, Rotondi MA, Behdin N, et al. (2022). "The association between shift work exposure and the variations in age at natural menopause among adult Canadian workers: results from the Canadian Longitudinal Study on Aging." Menopause. DOI: 10.1097/GME.0000000000001981. https://pubmed.ncbi.nlm.nih.gov/35324545/

Baseline Knowledge (what I know before searching)

Night work is not a more intense version of "late screens." Domestic nocturnal melanopic load describes light before sleep that suppresses or delays the darkness signal. Night work studies another architecture: a woman must be awake, alert, illuminated, eating, responding to occupational stress, and then trying to sleep during the biological day. The system receives contradictory zeitgebers: light and activity at night, darkness and incomplete rest during the day, meals in an adverse metabolic phase, shifted caffeine, operational cortisol out of phase, and repeated social jetlag.

The expected molecular pathway starts with retinal melanopsin/ipRGC -> SCN -> sympathetic pineal output -> AANAT/ASMT -> melatonin. But in night work, "low melatonin" is not enough. The SCN also organizes the HPA axis, core temperature, appetite, alertness, and signals toward KNDy/kisspeptin-GnRH-LH. The ovary is not a passive recipient: granulosa, theca, and corpus luteum cells have peripheral CLOCK/BMAL1 clocks that time StAR, CYP11A1, HSD3B, CYP19A1, LHCGR and responses to gonadotropins. If the central axis and ovarian clock fall out of phase, an isolated estradiol/progesterone measurement may look "normal," but the temporal pattern of ovulation, luteal phase, and symptoms degrades.

In LATAM this matters for nurses, physicians, caregivers, call centers, services, retail, security, transportation, and women with a double caregiving workload. The analysis must avoid medicalizing labor conditions: the hormonal phenotype may be real, but its cause may lie in work organization and available recovery.

The specific question the papers must answer is: is there epidemiological and endocrine evidence that night/rotating shifts alter the menstrual cycle, gonadotropins, melatonin, cortisol, sex steroids, or menopausal age in women?

Findings From Recent Papers

The epidemiological evidence is no longer anecdotal. Hu et al. 2023 meta-analyzed 21 studies with 195,538 women and found that shift work is associated with irregular menstruation (OR 1.30; 95% CI 1.23-1.36), dysmenorrhea (OR 1.35; 95% CI 1.04-1.75), and early menopause (HR 1.09; 95% CI 1.04-1.14). The signal was stronger in rotating night shifts (OR 1.34) and two-/three-rotating-shift systems (OR 1.44), and it was especially high in women <=30 years (OR 1.70). The critical limitation is that the review acknowledges limited representation from low- and middle-income countries, precisely where LATAM needs its own data.

Studies in nurses make it possible to estimate dose. Lawson et al. 2011, in 71,077 nurses from the Nurses' Health Study II, found that >=20 months of rotating night shifts in the prior two years were associated with irregular cycles (RR 1.23; 95% CI 1.14-1.33) and cycles >=40 days (RR 1.49; 95% CI 1.19-1.87). Mayama et al. 2020 found in 1,249 Japanese nurses that >=6 nights/month under two-shift rotating schedules was associated with irregular cycles (PR 1.78; 95% CI 1.34-2.35) and amenorrhea >=3 months (PR 2.39; 95% CI 1.27-4.50). Wang et al. 2016 observed that in Chinese nurses the proportion with 25-31-day cycles decreased from 81.7% to 67.8% after starting rotating work, and that >7 nights/month was linked to cycle shortening; the change did not recover over two years of follow-up.

Hormonal evidence confirms that the phenotype is not only "short sleep." Davis et al. 2012 measured nurses of reproductive age and found that, during daytime sleep in night workers, 6-sulfatoxymelatonin was 62% lower and FSH/LH were 62%/58% higher compared with night sleep in day workers. During night work, aMT6s was ~69% lower and FSH/LH were 35%/38% higher compared with night sleep in controls; even on nights off, aMT6s remained 42% lower. Bracci et al. 2014 showed that rotating-shift nurses, even after a day off and in the early follicular phase, had altered peripheral clock gene expression and higher 17-beta-estradiol. Fustinoni et al. 2025 added a new nuance: in hospital workers with rapid rotation, the pattern moved toward elevated adrenal steroids (corticosterone, 11-deoxycortisol, DHEA, androstenedione), lower estradiol and vitamin D, without simple changes in salivary cortisol/melatonin phase. Shift biology is not a single hormone: it is a change in steroid architecture.

For LATAM, Brum et al. 2022 is small but conceptually important: in a university hospital in southern Brazil, night workers slept ~3.68 h on workdays versus 6.66 h in day workers, with a shifted sleep midpoint and negative social jetlag near 6 h. The salivary cortisol rhythm appeared attenuated on workdays and days off. It is not a large female cohort, but it grounds the mechanism in a real Latin American labor context: night shift produces daytime sleep debt and incomplete recovery, not only light exposure.

Menopause requires caution. Stock et al. 2019 reported an association between rotating night work and menopausal age in the Nurses' Health Study II, whereas Khan et al. 2022 in the Canadian Longitudinal Study on Aging found an association with later menopause onset in some shift exposures. The conclusion for Lua Labs should not be "night shift advances menopause" universally. The more actionable variable is functional perimenopausal transition: fragmented sleep, vasomotor load, cycle irregularity, energy, and thermal stability before exact menopausal age.

Full Molecular/Endocrine Mechanism

Sustained night work should be modeled as a central-peripheral misalignment package:

Sustained night shift
  -> light + alertness + occupational stress during the biological night
  -> ipRGC/melanopsin -> SCN -> altered pineal output
  -> AANAT/ASMT low or out of phase -> low/delayed melatonin
  -> chronic melanopic load + loss of dark signal

Daytime sleep
  -> ambient light + noise + heat + family responsibilities
  -> compressed/fragmented sleep
  -> lower circadian amplitude + temperature out of phase
  -> poorer nocturnal thermoregulation
  -> insomnia, awakenings, AM/PM fatigue, luteal symptoms

Night work + meals/caffeine during the shift
  -> intake during the biological night
  -> melatonin/MTNR1B restrains pancreatic beta-cell secretion
  -> glucose/insulin out of phase + operational cortisol
  -> potentially lower SHBG + higher free androgens in insulin-resistant phenotypes
  -> chronometabolic and luteal vulnerability

Misaligned SCN/HPA
  -> cortisol awakening response in a shifted or flattened window
  -> altered GR/PR cross-talk
  -> KNDy/kisspeptin -> noisier GnRH pulses
  -> LH/FSH out of phase
  -> less coherent folliculogenesis, ovulation, and luteal function

LH/FSH + peripheral ovarian clock
  -> CLOCK/BMAL1 granulosa/theca/corpus luteum
  -> StAR -> CYP11A1 -> pregnenolone
  -> HSD3B -> progesterone
  -> CYP17A1/CYP19A1 -> androgens/estradiol
  -> LHCGR/PTGS2 -> ovulation and luteinization
  -> degraded temporal E2/P4 output even if point values may vary

The central mechanistic point is that night shift introduces three simultaneous collisions:

Light-dark collision: melatonin loses amplitude or phase.
Food-biological night collision: insulin, glucose, SHBG, and appetite work against the metabolic clock.
Work-recovery collision: HPA/cortisol and cognitive demand activate when the reproductive system needs stable nighttime signals.

In perimenopause, the chain becomes more fragile:

Intermittent P4 + fluctuating E2 + vasomotor load
       +
melatonin/circadian amplitude declining with age
       +
night/rotating shift
       ->
functional collapse of the dark signal
       ->
insufficient daytime sleep, unstable temperature, cycles perceived as erratic
       ->
symptomatic perimenopausal transition before a clear menstrual signal

Lua Labs Hypotheses

Hypothesis 41: SWCD — Shift-Work Chronodisruption Dose

Statement: In women with night or rotating shifts, a composite dose of occupational chronodisruption predicts menstrual irregularity, low energy, and luteal symptoms better than counting sleep hours or screen exposure separately.

Proposed mechanism: SWCD integrates frequency of nights/month, rotation, compressed daytime sleep, food/caffeine during the biological night, occupational melanopic load, recovery between shifts, and hormonal phase. The proposed chain is:

Nights/month + rotation + short recovery
  -> chronic melanopic load + fragmented daytime sleep
  -> low/delayed melatonin + flattened cortisol
  -> GnRH/LH/FSH out of phase + misaligned ovarian CLOCK/BMAL1
  -> cycle/ovulation variability + luteal symptoms + fatigue

Confidence level: Medium-high — the epidemiological association with menstrual irregularity is robust; the hormonal chain is supported by melatonin, LH/FSH, clock genes, and cortisol; longitudinal validation in LATAM is missing.

How to validate:

With a formal study: prospective observational cohort in nurses/call centers/caregivers, n=600, 6 months; subcohort n=120 with urinary aMT6s, salivary cortisol, and serial LH/FSH/E2/P4 by phase.

Limitations: Healthy worker bias may hide effects in those who leave shift work. Self-selection by chronotype and economic need confounds exposure. Shift quality matters: one night in an ICU is not equivalent to one night in a call center. SWCD should not be turned into an individual behavioral judgment.

Hypothesis 42: Luteal Window of Vulnerability to Night Shift

Statement: The same night shift produces greater symptomatic cost when it occurs in the mid-to-late luteal phase than in the follicular phase, even if acute melatonin suppression does not strongly depend on phase.

Proposed mechanism: In the luteal phase, progesterone and allopregnanolone raise basal temperature, modify GABA-A, alter ventilation/thermoregulation, and reduce the margin for dissipating nocturnal heat. If the shift adds light, activity, caffeine, and food, synchrony between the darkness signal, progesterone, and thermoregulation breaks:

Mid-to-late luteal phase
  -> P4/ALLO + high temperature + lower central insulin buffer
  -> night shift: light + food + operational cortisol
  -> low melatonin + food-biological night collision + occupational melanopic load
  -> more awakenings, irritability, cravings, pain, low energy

Confidence level: Medium — strong mechanistic plausibility from chronobiological evidence and epidemiological evidence of dysmenorrhea/irregularity; studies stratifying shift by phase with daily measurement are missing.

How to validate:

With a formal study: case-crossover design, n=150 women with active cycles and rotating shifts, 3 cycles, ovulatory confirmation by urinary LH or luteal progesterone.

Limitations: Calendar-estimated phase can fail if shift work has already altered ovulation. Hormonal contraceptives, PCOS, lactation, and anovulatory cycles require stratification.

Hypothesis 43: Perimenopausal Fragility From Night Shift

Statement: In early perimenopause, sustained night work amplifies symptoms of hormonal transition before detectably modifying menopausal age; the relevant outcome is nocturnal fragility, not universal "advanced menopause."

Proposed mechanism: In women 42-52, intermittent P4, fluctuating E2, greater vasomotor load, and lower circadian amplitude make the biological night more vulnerable. Night shift reduces the ability to recover the darkness signal:

Early perimenopause
  -> intermittent P4 + vasomotor load + vulnerable sleep
  -> night/rotating shift
  -> less recoverable melatonin + flattened cortisol + short daytime sleep
  -> night hot flashes, awakenings, fatigue, cycles perceived as "strange"
  -> symptomatic transition before a clear change in menopausal age

Confidence level: Medium-low — the biology is coherent, but evidence on menopausal age is mixed and probably depends on labor survival, cumulative exposure, and shift definition.

How to validate:

With a formal study: perimenopausal occupational cohort n=500, 18-month follow-up, outcomes of vasomotor load, sleep fragmentation, cycle variability, and optional FSH/E2/AMH markers; do not use menopausal age as the only endpoint.

Limitations: Perimenopause has high natural variability. Night shift may correlate with stress, socioeconomic level, family caregiving, and health access. There is a risk of blaming women for a structural exposure.

Individual Variability

The same night exposure does not produce the same effect in everyone. Evening chronotype may tolerate fixed night shift better than rapid rotation, but even then social/family life may prevent recovery. Women with morning chronotype, childcare, long commutes, or double workload have less biological margin. The luteal phase, through temperature and progesterone, probably amplifies cost; perimenopause adds vasomotor load and lower resilience of the dark signal.

Genetically, variants in CLOCK/ARNTL/PER3/CRY, OPN4 (melanopsin), MTNR1B (pancreatic beta-cell response to melatonin), NR3C1/FKBP5 (glucocorticoid sensitivity), INSR/IRS1/TCF7L2 (insulin), and COMT/CYP1A1/CYP19A1 (steroid metabolism) can modulate response. In women with PCOS or insulin resistance, the same shift may appear as cravings, acne, irregularity, or low energy; in perimenopause, as awakenings, nocturnal heat, somatic anxiety, or cycles that "feel" disordered.

The most important environmental factor may be social: control over the schedule, ability to sleep during the day, light exposure during morning commute, home noise/heat, neighborhood safety, care for children or older adults, and economic need. In LATAM, these modulators are not statistical noise; they are part of the real mechanism.